BERLDRG logo

Beryl Drugs Ltd

BERLDRG·BSE·
24.89 +1.05 (+4.40%)
Market Cap12.40 Cr
PE Ratio21.83
Volume3,925
Day High - Low26.50 - 22.62
52W High-Low27.09 - 15.92
DocStoX Score
5.0/10
Weak
Fair Value
Sign in to see
ROE
4.33%
Weak
P/E
21.83x
Fair
Debt / Equity
0.25
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed

Price performance

Day22.62
26.50
52W15.92
27.09
DocStoX take

Supported by momentum (7.5) and growth (6.3), but held back by quality (2.7). Momentum looks strong at 7.5, but that is offset by quality at 2.7. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
5.0
/10
Weak
Quality
Weak
ROE 4.3%
Valuation
Rich
P/E 21.8×
Growth
Steady
Revenue +6.0% 5Y CAGR
Risk
Moderate
D/E 0.25
Momentum
Strong
80% of 52-week range

At a glance

Market Cap
₹12 Cr
52W High / Low
₹27 / ₹16
Dividend Yield
0.00%
Promoter Holding
27.82%
EPS (TTM)
₹1.14
Book Value
₹19.44

Key highlights

  • Small ₹12 cr company — thinner liquidity
0 Positives1 Watchout

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

Beryl Drugs Ltd peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.